Goldenrod Therapeutics
Manufacturing · Texas, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3900 Essex Ln Ste 575, Houston, Texas, 7...Website
www.goldenrodtx.comRevenue
<$5 MillionIndustry
About Goldenrod Therapeutics
Goldenrod Therapeutics is a biotechnology company developing next-generation brain-penetrant phosphodiesterase 4 (PDE4) inhibitors for serious neurological and neuroinflammatory disorders. The company focuses on creating small-molecule therapies designed to improve treatment options for conditions including neurodegenerative diseases, substance use disorders, and other CNS-related indications. Its lead program, 11h, aims to address limitations of earlier PDE4 inhibitors through improved selectivity and brain exposure.Explore more
SIC Code 28,283NAICS Code 32,325Show moreGoldenrod Therapeutics Org Chart
Goldenrod Therapeutics Tech Stack
A closer look at the technologies used by Goldenrod Therapeutics
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Goldenrod Therapeutics
Sign Up For FreeTo access detailed company insights
Goldenrod Therapeutics is a biotechnology company developing next-generation brain-penetrant phosphodiesterase 4 (PDE4) inhibitors for serious neurological and neuroinflammatory disorders. The company focuses on creating small-molecule therapies designed to improve treatment options for conditions including neurodegenerative diseases, substance use... Read More
